User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications from active P30 Cancer Center Support Grants (CCSG) to support an expansion of cancer research conducted in a cancer center by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program into a pilot cancer research project.
As a component of the NCI IMAT program , this NOFO is meant to promote interdisciplinary collaboration in the development of innovative tools and methods as well as incentivize independent validation and accelerate the suitability of these emerging technologies to enable cancer research and accelerate scientific discovery.
Deadlines:
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Renewal / Resubmission / Revision Due Date(s): April 1, 2024; Oct. 1, 2024
RFA-CA-24-015 Expiration Date October 02, 2024
Specialties
Eligibility Requirements
Sponsor Details
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Grant
Final Deadline:
Oct 01, 2024
Funding Amount:
$300,000
Host Details
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts